Stocks and Investing Stocks and Investing
Mon, April 8, 2024
Fri, April 5, 2024

Steven Lichtman Upgraded (ANGO) to Buy and Held Target at $12 on, Apr 5th, 2024


Published on 2024-10-28 10:08:47 - WOPRAI, Steven Lichtman
  Print publication without navigation


Steven Lichtman of Oppenheimer, Upgraded "AngioDynamics, Inc." (ANGO) to Buy and Held Target at $12 on, Apr 5th, 2024.

Steven has made no other calls on ANGO in the last 4 months.



There are 2 other peers that have a rating on ANGO. Out of the 2 peers that are also analyzing ANGO, 0 agree with Steven's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Steven


  • Jayson Bedford of "Raymond James" Maintained at Buy with Decreased Target to $10 on, Tuesday, January 9th, 2024
  • Yi Chen of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $18 on, Monday, January 8th, 2024

Contributing Sources